随着国家药品集中带量采购常态化推进,前四批部分药品陆续到期,并陆续开展第一批、第三批接续工作。本文拟分析国家药品集中采购第一批、第三批接续模式,提炼分析不同地区及联盟接续模式,分析部分地区第一批、第三批实践效果及第二批、第四批接续环境和政策要求变化,为国家集采常态化制度化推进下接续规则优化提出政策建议。
Abstract
With the normalization of the national centralized drug procurement, some of the first four batches of drugs have expired, and follow-up procurement of the first and the third batch have been carried out. This paper attempts to analyze the first and third batch of follow-up mode, refine and analyze the follow-up modes of different regions and alliances, analyze the effects of the first and third batches in some regions and the changes in the follow-up environment and policy requirements of the second and fourth batches, and put forward policy suggestions for the optimization of follow-up rules.
关键词
带量采购 /
集中采购 /
接续模式
Key words
volume procurement /
centralized procurement /
follow-up mode
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
[1] 陈珉惺,吴卿仪,徐源,等.国家药品集中带量采购接续政策的分析与建议[J]. 中国卫生资源,2022,25(03):273-277.
[2] 孙冬悦,罗宁泰,江滨.“四批五轮”后的药品集采续约方案[J]. 中国卫生,2021,(03):34-35.
[3] 李大双,颜建周,白铭钰,等.国家组织药品集中采购供应问题及对策研究[J]. 卫生经济研究,2022,39(06):12-16.
[4] 祁鹏,郭丹,赵曦萌,等.国家组织药品集采协议期满后省际联盟接续采购分析[J]. 中国医疗保险,2022,(05):22-25.
[5] 谭清立,高江源,林岱衡.药品集中带量采购政策与我国医保支付制度的协同作用探讨[J]. 中国药房,2021,32(02):146-151.
基金
上海市2022年度“科技创新行动计划”软科学研究《国家药品集中带量采购常态化下的上海接续政策完善与产业格局优化》 (22692191900); 国家卫生健康委《药品和高值医用耗材集中采购结余资金使用等关键问题前瞻研究》